TrialOncotarget2017

Effectiveness and safety of sorafenib in the treatment of unresectable and advanced intrahepatic cholangiocarcinoma: a pilot study.

Xiangji Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.